Revolution Medicines, Inc 10-Q for FY2024 Q3
Revolution Medicines, Inc. (RVMD)
10-Q
2024-11-06
For: 2024-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on November 6, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).
Headline figures
Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $0 a year earlier
- Net loss
- $156.29M
- compared with a net loss of $108.43M a year earlier
- Diluted EPS
- -$0.94
- compared with -$0.99 a year earlier